These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17915156)

  • 21. Prediction of survival of patients in cardiogenic shock treated by surgically implanted Impella 5+ short-term left ventricular assist device.
    Nersesian G; Tschöpe C; Spillmann F; Gromann T; Roehrich L; Mueller M; Mulzer J; Starck C; Falk V; Schoenrath F; Potapov E
    Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):475-482. PubMed ID: 32879947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro comparison of support capabilities of intra-aortic balloon pump and Impella 2.5 left percutaneous.
    Schampaert S; van't Veer M; van de Vosse FN; Pijls NH; de Mol BA; Rutten MC
    Artif Organs; 2011 Sep; 35(9):893-901. PubMed ID: 21819436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
    Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
    J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock.
    Ogawa S; Suzuki M; Ochi H; Saji M; Mahara K; Takamisawa I; Nishigawa K; Furuichi Y; Takanashi S; Isobe M
    Intern Med; 2019 May; 58(10):1459-1462. PubMed ID: 30626823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience.
    Engström AE; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; de Jong M; Lagrand WK; van der Sloot JA; Tijssen JG; de Winter RJ; de Mol BA; Piek JJ; Henriques JP
    Crit Care Med; 2011 Sep; 39(9):2072-9. PubMed ID: 21602670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous Ventricular Assist Devices: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(2):1-97. PubMed ID: 28232854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved results for postcardiotomy cardiogenic shock with the use of implantable left ventricular assist devices.
    DeRose JJ; Umana JP; Argenziano M; Catanese KA; Levin HR; Sun BC; Rose EA; Oz MC
    Ann Thorac Surg; 1997 Dec; 64(6):1757-62; discussion 1762-3. PubMed ID: 9436568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiogenic shock secondary to severe acute ischemic mitral regurgitation managed with an Impella 2.5 percutaneous left ventricular assist device.
    Harmon L; Boccalandro F
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1129-34. PubMed ID: 21805597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous ventricular assist devices for cardiogenic shock.
    Cook S; Windecker S
    Curr Heart Fail Rep; 2008 Sep; 5(3):163-9. PubMed ID: 18752766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanical circulatory support with the Thoratec assist device in patients with postcardiotomy cardiogenic shock.
    Körfer R; el-Banayosy A; Posival H; Minami K; Kizner L; Arusoglu L; Körner MM
    Ann Thorac Surg; 1996 Jan; 61(1):314-6. PubMed ID: 8561596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock.
    Meyns B; Dens J; Sergeant P; Herijgers P; Daenen W; Flameng W
    Thorac Cardiovasc Surg; 2003 Dec; 51(6):312-7. PubMed ID: 14669126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bail-Out Use of Impella CP as a Bridge to TAVI in a Cardiogenic Shock Patient: The "Pump-Rewiring" Technique.
    Burzotta F; Nerla R; Trani C
    J Invasive Cardiol; 2016 Jan; 28(1):E1-5. PubMed ID: 26716594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful Use of Surgically Placed Impella 5.0 and Central Extracorporeal Membrane Oxygenation Circuit in a Patient with Postcardiotomy Shock.
    Abu Saleh WK; Mason P; Jabbari OA; Samir H; Bruckner BA
    Tex Heart Inst J; 2015 Dec; 42(6):569-71. PubMed ID: 26664314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient management.
    Gacioch GM; Ellis SG; Lee L; Bates ER; Kirsh M; Walton JA; Topol EJ
    J Am Coll Cardiol; 1992 Mar; 19(3):647-53. PubMed ID: 1538023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous ventricular assist device support during off-pump surgical coronary revascularization.
    Gregoric ID; Poglajen G; Span M; Frazier OH; Loyalka P; Kar B
    Ann Thorac Surg; 2008 Aug; 86(2):637-9. PubMed ID: 18640347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thirty-five day Impella 5.0 support via right axillary side graft cannulation for acute cardiogenic shock.
    Castillo-Sang MA; Prasad SM; Singh J; Ewald GA; Silvestry SC
    Innovations (Phila); 2013; 8(4):307-9. PubMed ID: 24145977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?
    Syed AI; Kakkar A; Torguson R; Li Y; Ben-Dor I; Collins SD; Lemesle G; Maluenda G; Xue Z; Scheinowitz M; Kaneshige K; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Cardiovasc Revasc Med; 2010; 11(2):91-7. PubMed ID: 20347798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporary mechanical circulatory support with Impella in cardiac surgery: A systematic review.
    Pieri M; D'Andria Ursoleo J; Nardelli P; Ortalda A; Ajello S; Delrio S; Fominskiy E; Scandroglio AM
    Int J Cardiol; 2024 Feb; 396():131418. PubMed ID: 37813286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impella ventricular assist device: use in patients at high risk for coronary interventions: successful multivessel percutaneous coronary intervention in a 62-year-old high-risk patient.
    Marella PC; Lassetter JE; Heuser RR
    Cardiovasc Revasc Med; 2011; 12(1):69.e9-12. PubMed ID: 21036108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.